Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured patients
- Posted on February 24, 2026
- By CNBC
- 3 Views
Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured patients
The cuts aim to make the drugs more accessible to insured patients, particularly people with high-deductible health plans or co-insurance benefit designs.
